Latest Regulatory Compliance News

Cobalt Blue Holdings has completed the issuance of over 22 million shares following a placement announced earlier this month, leveraging its ASX capacity. The move marks a key step in the company’s capital strategy without requiring additional disclosure.

The NSW Independent Casino Commission has prolonged the suspension of The Star Sydney casino licence and extended the manager’s term, signaling ongoing regulatory scrutiny and remediation efforts.

Emu NL has agreed to delay issuing shortfall securities from its entitlement offer until after its extraordinary general meeting on 29 September 2025, following a regulatory undertaking accepted by the Takeovers Panel.

Aldoro Resources has updated the timetable for distributing Sultan Consideration Shares following recent asset divestments, with shareholder approval set for November.

360 Capital Mortgage REIT has announced an estimated ordinary dividend of AUD 0.055 per security for the September quarter, alongside the adoption of the Attribution Managed Investment Trust regime and a Dividend Reinvestment Plan offering.

Hydrix Limited has responded to an ASX query following a sudden surge in its share price and trading volume, denying any undisclosed material information and reaffirming compliance with listing rules.

The Lion Series 2020-1 Trust has completed the redemption of its $920 million Class A1 floating rate notes, leading to their suspension and removal from the ASX official list.

Haranga Resources confirms that the Lincoln Gold Project in California is production ready, with critical permits approved and infrastructure in place, setting the stage for a rapid restart.

MetalsTech Limited has completed a significant off-market block trade involving 4 million shares worth nearly $2 million, signaling notable shifts among its substantial shareholders.

Klevo Rewards Limited has initiated a non-renounceable entitlement offer to raise up to $4.1 million by issuing new shares at $0.009 each, inviting existing shareholders to participate by 1 October 2025.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.